Publications by authors named "Daniel Reck"

Claim this Profile
B
Benefits of dapagliflozin in chronic kidney disease for US commercial payers: A cost-offset analysis.
Raymond C Chang, Joanna Huang, James Hurst, Daniel Reck, Kat Khachatourian

J Manag Care Spec Pharmยท August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis